A mother of three was blindsided by a cervical cancer diagnosis just days before her 30th birthday — despite experiencing ...

A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...

Arsenal is using its platform to drive awareness of a major women’s health issue, joining a campaign set to make a lasting ...

A new cervical cancer treatment is showing promise in boosting survival rates and reducing recurrence What this breakthrough means for patients.

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

With proper screening, vaccination, and awareness, we can significantly reduce cervical cancer cases. It is crucial to ...

Cervical cancer is the 14th most common cancer in females in the UK, affecting roughly 3,300 people every year. But the disease is often called a 'silent killer' because its symptoms can be easily ...

Researchers led by the Africa Centers for Disease Control (Africa CDC) will establish three Centers of Excellence in Rwanda, Morocco, and Zambia to gather evidence and accelerate efforts to end ...

Chemoradiation with platinum-based chemo is standard for locally advanced cervical cancer, but adverse events drive ...

This is an educational message sponsored by MSD Philippines. Valentine’s Day is traditionally a time for chocolates, flowers, and romantic dinners. But what if this year, you and your partner focused ...

DARE-HPV is an innovative investigational treatment for HPV-related cervical disease. Essentially all cervical cancers worldwide are caused by HPV infection, and despite the advancements in HPV ...